JENNIFER LEE: Open Payments
NPI 1114426053 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 19 payments from 14 companies in 2025. Trend: 2023 $26 · 2024 $25 · 2025 $455
Food & beverage: $375Education: $80
| Company | Payments | Amount |
|---|---|---|
| SEAGEN INC. | 1 | $80 |
| Janssen Biotech, Inc. | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 3 | $51 |
| ABBVIE INC. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| SOBI, INC | 1 | $24 |
| Geron Corporation | 1 | $24 |
| SERVIER PHARMACEUTICALS LLC | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $21 |
Products named: EPKINLY, DARZALEX, RYBREVANT, Doptelet, RYTELO, Asparlas, KEYTRUDA, Orserdu.
Industry payments across OK — which companies pay providers there.
